Epstein Secrets

ilding; 10:00 AM * House Small Business subcommittee hybrid hearing on `Preventing Fraud and Abuse of PPP and EIDL' - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on `Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government Accountability

g on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Lat

lding; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government Accountability

g on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in Lat

ing; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL' - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government Accountability

ring on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in La

ing; 10:00 AM • House Small Business subcommittee hybrid hearing on 'Preventing Fraud and Abuse of PPP and EIDL' - Investigations, Oversight, and Regulations Subcommittee hybrid hearing on EFTA01658535 'Preventing Fraud and Abuse of PPP and EIDL: An Update with the SBA Office of Inspector General and the Government

ng on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission virtual hearing on enforced disappearance in La